MAPT and Cognitive impairment: The fact that the control group (inactivated HIV-gp120 + Tau) did not show any effect on the Y-maze test demonstrated that during the treatment time (10 days), the Tau mice did not develop cognitive deficits (independent of HIV-gp120 action) that could be confounded with HIV-gp120 action.